Aprea Therapeutics, Inc. (APRE) - Latest Market Data

Price & Market Data

Price: $0.96

Daily Change: +$0.03 / 3.12%

Daily Range: $0.826 - $0.97

Market Cap: $11,763,637

Daily Volume: 194,066

Performance Metrics

1 Week: -2.15%

1 Month: -3.20%

3 Months: 11.18%

6 Months: -18.90%

1 Year: -44.09%

YTD: 3.33%

About Aprea Therapeutics, Inc. (APRE)

Comprehensive market data and analysis for Aprea Therapeutics, Inc. (APRE). Current price: 0.96, daily change: +$0.03 / 3.12%. Market cap: 11,763,637. View detailed YTD, 1-week, and 1-month performance.

Company Details

Employees: 8

Sector: Health technology

Industry: Pharmaceuticals: major

Country: United States

Details

Aprea Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel synthetic lethality-based cancer therapeutics that targets DNA damage response pathways. Its lead product candidates are APR-1051, an orally bioavailable small-molecule inhibitor of WEE1 kinase that is in Phase 1 clinical trial for the treatment of patients with advanced solid tumors with biomarkers and ATRN-119, an ATR inhibitor, which is in Phase 1/2a clinical trial for solid tumor indications. The company is headquartered in Doylestown, Pennsylvania.

Selected stocks

Rani Therapeutics Holdings, Inc. (RANI)

ClearSign Technologies Corporation (CLIR)

Micropolis AI Robotics (MCRP)

Offerpad Solutions Inc. (OPAD)